Treatment of nicotine craving and/or smoking withdrawal symptoms
US5599554A · kind A · utility
54Cited by
17References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 19, 1996 |
| Grant date | Feb 4, 1997 |
| Priority date | — |
| Expiry date | Mar 19, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/7069
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention encompasses a transdermally or transmucosally administrable composition for the treatment or nicotine craving or smoking withdrawal symptoms comprising nicotine and caffeine or caffeine equivalent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.